RXRA and cancer: In cancer cells, RARα/RXRα (NR1B1/NR2B1) interacts with Sp1 and Sp3 on the 17β-hydroxysteroid dehydrogenase type 2 (HSD17B2) promoter, and retinoic acid (RA) induces its expression [83].